-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

632. Chronic Myeloid Leukemia: Clinical and Epidemiological: Poster III

Program: Oral and Poster Abstracts
Type: Poster
Monday, December 13, 2021: 6:00 PM-8:00 PM
Hall B5, Level 1, Building B (Georgia World Congress Center)

Jiang Qian, MD1, Dayu Shi2*, Zongru Li2*, Yue Hou3*, Yu Hu4*, Weiming Li5*, Xiaoli Liu6*, Na Xu6*, Yongping Song7*, Gongli Zhang8*, Li Meng9*, Zhenya Hong9*, Bingcheng Liu10*, Yan Li11*, Suning Chen12*, Mengxing Xue13*, Huanling Zhu14*, He Li14*, Xin Du15*, Jin Lou16*, Xiaohan Zhang16*, Yang Liang, MD, PhD17, Yujun Dai, MD, PhD18*, Zi Chen19*, Qian Niu19*, Lichuang Men19*, Dajun Yang20,21*, Yifan Zhai19,22 and Xiaojun Huang23

1Peking University Institute of Hematology, Peking University People's Hospital, Beijing, Beijing, China
2Peking University Institute of Hematology, Peking University People’s Hospital, Beijing, China
3Peking University Institute of Hematology, Peking University People's Hospital, Beijing, China
4Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
5Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
6Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
7Department Hematology, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China
8Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China
9Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
10Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China
11Institute of Hematology and Blood Diseases Hospital, National Clinical Research Center for Blood Diseases, Tianjin, China
12National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China
13Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China
14Department of Hematology, West China Hospital of Sichuan University, Chengdu, China
15Division of Hematology, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, CA, China
16Division of Hematology, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, China
17Department of Hematologic Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China
18Department of Hematologic Oncology, Sun Yat-sen University Cancer Center, Shanghai, China
19Guangzhou Healthquest Pharma Co. Ltd., Guangzhou, China
20Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Guangzhou, China
21Ascentage Pharma (Suzhou) Co., Ltd., Suzhou, China
22Ascentage Pharma Group Inc., Rockville, MD
23Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, 2019RU029, Beijing China, Beijing, China

David Andorsky, MD1*, Sarah Tomassetti2, Yehuda E. Deutsch, MD3, E Randolph Broun, MD4, Ghayas C. Issa, MD5, Moshe Y. Levy, MD6, Michael W. Deininger, MD, PhD7, Rodrigo Maegawa, MD, MBA8*, Alok Shrestha8* and Michael J. Mauro, MD9

1Rocky Mountain Cancer Centers, Boulder, CO
2Harbor-UCLA Medical Center and The David Geffen School of Medicine at UCLA, Redondo Beach, CA
3Department of Malignant Hematology and Cellular Therapy at Memorial Health System, Moffitt Cancer Center, Pembroke Pines, FL
4Oncology Hematology Care, Inc., Cincinnati, OH
5Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
6Baylor Scott & White Research Institute, Dallas, TX
7Division of Hematology and Hematologic Malignancies, University of Wisconsin Milwaukee, Milwaukee, WI
8Novartis Pharmaceuticals Corporation, East Hanover, NJ
9Myeloproliferative Neoplasms Program, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY

Milad Rouhimoghadam, PhD1*, Anthony D. Pomicter, MS1*, Alexandria Van Scoyk, BS1*, Greg Poffenberger, MS1*, Ivaylo Kirov, MS2*, Lyubomir G. Nashev, PhD2*, Helong Zhao, PhD1*, Martin Martinov, PhD3* and Michael W. Deininger, MD, PhD1,4

1Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
2Gradient Bulgaria, Sofia, Bulgaria
3FAR Biotech, Houston, TX
4Division of Hematology and Hematologic Malignancies, University of Utah, Salt Lake City, UT

Takashi Kumagai, MD, PhD1, Kazunori Murai, MD, PhD2, Hiroshi Ureshino, MD3*, Hideo Tanaka, MD, PhD4*, Kaichi Nishiwaki, MD5*, Satoshi Wakita, MD6*, Koiti Inokuchi, MD, PhD, Prof.6*, Toshihiro Fukushima, MD7*, Chikashi Yoshida, MD, PhD8, Masayuki Mita, MD9*, Nobuhiko Uoshima, MD, PhD10*, Toru Kiguchi, MD, PhD11*, Jun Aoki, MD12*, Satoshi Kimura, MD13*, Kaori Karimata, MD14*, Kensuke Usuki, MD, PhD15, Joji Shimono, MD16*, Yoshiaki Chinen, MD, PhD17*, Junya Kuroda, MD, PhD17, Yasufumi Matsuda, MD18*, Kensuke Nakao, MD19*, Takaaki Ono, MD, PhD20*, Katsumichi Fujimaki, MD, PhD21*, Hirohiko Shibayama, MD, PhD22, Chisaki Mizumoto, MD23*, Tomoharu Takeoka, MD, PhD24*, Katsuhiro Io, MD25*, Takeshi Kondo, MD, PhD26, Masatomo Miura27*, Yosuke Minami, MD, PhD28, Takayuki Ikezoe, MD, PhD29, Jun Imagawa, MD30*, Ayako Takamori31*, Atsushi Kawaguchi, PhD32*, Junichi Sakamoto, MD, PhD33* and Shinya Kimura, MD, PhD3*

1Department of Hematology, Ome Municipal General Hospital, Tokyo, Japan
2Department of Hematology, Iwate Prefectural Central Hospital, Morioka, Japan
3Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga-city, Japan
4Department of Hematology, Hiroshima City Asa Hospital, Hiroshima, Japan
5Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University Kashiwa Hospital, Kashiwa, CHI, Japan
6Department of Hematology, Nippon Medical School, Tokyo, Japan
7Department of Hematology and Immunology, Kanazawa Medical University, Kanazawa, Japan
8Department of Hematology, National Hosp. Organization Mito Medical Center, Ibaraki, Japan
9Department of Hematology,, Shirakawa Kosei General Hospital, Shirakawa, Japan
10Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan
11Department of Hematology, Chugoku Central Hospital, Fukuyama, HIR, Japan
12Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan
13Department of Hematology, Fukushima Medical University, Fukushima, JPN
14Department of Hematology, Heart Life Hospital, Nakagusuku, Japan
15Department of Hematology, NTT Medical Center, Tokyo, Japan
16Department of Hematology, Asahikawa City Hospital, Asahikawa, Japan
17Division of Hematology and Oncology, Deparment of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan
18Department of Hematology and Oncology, University of Fukui, Fukui, Japan
19Department of Hematology/Oncology, Shiga General Hospital, Moriyama, Japan
20Divison of Hematology, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan
21Department of Hematology, Fujisawa City Hospital, Fujisawa, Japan
22Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Japan
23Division of Haematology and Immunology, Otsu Red Cross Hospital, Otsu, Japan
24Department of Haematology and Immunology, Otsu Red Cross Hospital, Ohtsu, Japan
25Department of Hematology, Kansai Electric Power Hospital, Osaka, Japan
26Blood Disorders Center, Aiiku Hospital, Sapporo, Japan
27Department of Pharmacy, Akita University Hospital, Akita, Japan
28Department of Hematology, National Cancer Center Hospital East, Kashiwa, Japan
29Dept. of Hematology, Fukushima Medical University, Fukushima, Japan
30Department of Haematology and Oncology, Res. Inst. For Radiation Biology & Medicine, Hiroshima Univ., Hiroshima, JPN
31Clinical Research Center, Saga University Hospital, Saga, Japan
32Education and Research Center for Community Medicine, Faculty of Medicine, Saga University, Saga, Japan
33Tokai Central Hospital, Kakamigahara, Japan

Morgane Froment1*, Meinolf Suttorp2, Stéphanie Ragot3*, Hélène Deutsch, MD1*, Violaine Goyeau1*, Barbara De Moerloose, MD4*, Silvia Regina Brandalise5*, Marina Borisevich6*, Petr Sedlacek, MD7*, Adalet Meral Gunes8*, Birgitte Lausen9*, Antonio Molines Honrubia10*, Gordana Jakovljevic, MD11*, Birgitta Versluys12*, Krzysztof Kalwak13*, Andrea Hraskova, MD14* and Frederic Millot, M.D.1*

1Department of Pediatric Hematology-Oncology, University Hospital Poitiers, Poitiers, France
2Pediatric Hemato-Oncology, Medical Faculty, Technical Univ. Dresden, Dresden, Germany
3Inserm CIC 1402, University Hospital, Poitiers, France
4Dept of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium
5Dr. Domingus A. Boldrini Children’s Center for Hematologic Research, Campinas, Brazil
6Belarusian Research Centre for Paediatric Oncology, Haematology and Immunology, Minsk, Belarus
7Department of Pediatric Hematology and Oncology, Charles University and University Hospital Motol, Prague, Czech Republic
8Uludağ University Faculty of Medicine, Bursa, Turkey
9Rigshospitalet, National University Hospital, Copenhagen, DNK
10Servicio de Hematología y Hemoterapia, Complejo Hospitalario Universitario Insular Materno Infantil, Las Palmas de Gran Canaria, Spain
11Department of Pediatric Hematology Oncology Immunology and Medical Genetic, Children Hospital, Zagreb, Croatia
12Pediatric Oncology and Hematology, Wilhelmina Children’s Hospital/UMC Utrecht, Utrecht, Netherlands
13Department of Pediatric Hematology, Oncology and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland
14University Children's Hospital, Bratislava, Slovakia

Massimo Breccia, MD1*, Luigia Luciano, MD2, Mario Annunziata, MD3*, Imma Attolico, MD4*, Alessandra Malato, MD, PhD5*, Elisabetta Abruzzese, MD6, Massimiliano Bonifacio, MD7*, Anna Rita Scortechini, MD8*, Nicola Cascavilla, MD9, Nicola Di Renzo, MD10*, Stefana Impera, MD11*, Monia Lunghi, MD, PhD12*, Marco Santoro, MD, PhD13*, Fausto Castagnetti, MD, PhD14, Alessandro Maggi, MD15*, Valeria Sargentini16*, Alfonso Piciocchi, MS16*, Claudia Galimberti17* and Alessandra Iurlo, MD, PhD18*

1Division of Hematology, Department of Translational and Precision Medicine, Azienda Policlinico Umberto I, Sapienza University, Rome, Italy
2Hematology Unit, Federico II University of Naples, Napoli, Italy
3Hematology Unit, Azienda Ospedaliera Cardarelli, Naples, Italy
4Haematology and Transplants Unit, University of Bari, Bari, Italy
5Department of Hematology, Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy
6Hematology, S. Eugenio Hospital, Tor Vergata University, Rome, Italy
7Department of Medicine, Section of Hematology, University of Verona, Verona, Italy
8Division of Hematology, Department of Molecular and Clinical Sciences, Polytechnic University of Marche, Ancona, Italy
9Division of Hematology, IRCCS Casa Sollievo Della Sofferenza Hospital, San Giovanni Rotondo, Italy
10Department of Hematology and Stem Cell Transplant, Presidio Ospedaliero Vito Fazzi, Lecce, Italy
11Division of Hematology, ARNAS Garibaldi, Catania, Italy
12Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy
13Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Palermo, Italy
14Istituto di Ematologia “Seràgnoli”, Department of Experimental, Diagnostic and Specialty Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, University of Bologna, Bologna, Italy
15Division of Hematology, Hospital "S.G. Moscati", Taranto, Italy
16GIMEMA Foundation, Rome, Italy
17Medical Department, Incyte Biosciences Italy S.R.L, Milan, Italy
18Hematology Division, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy

Hyacinthe Johnson-Ansah, MD1,2*, Aude Charbonnier, MD, PhD1,3*, Delphine Rea, MD, PhD4,5, Gabriel Etienne, MD, PhD6,7*, Lydia Roy, MD6,8*, Laurence Legros, MD, PhD1,9*, Agnes Guerci Bresler, MD10*, Anne Bouvier, MD PhD11*, Emilie Cayssials, MD12,13*, Valerie Coiteux, MD14*, Philippe Rousselot6,15*, Stephanie Dulucq, PharmD, PhD6,16*, Sandrine Hayette, PhD6,17*, Francois-Xavier Mahon, MD, PhD6,18 and Franck E. Nicolini, MD, PhD6,19,20

1Institut Bergonié, French Group of CML, Bordeaux, France
2Institut d'Hématologie de Basse-Normandie, CHU de Caen Normandie, Caen, France
3Hematology department, Institut Paoli Calmettes, Marseille, FRA
4Université de Paris, Hematology department, Saint-Louis hospital, APHP, Paris, France
5Fi-LMC group, Paris, France
6Fi-LMC group, Pessac, France
7Institute Bergonie; Institut National de la Sante et de la Recherche Medicale; Groupe France Intergroupe des Leucemies Myeloides Chroniques, Hopital Haut-Leveque, Pessac, France
8Hematology department, Hopital Henri Mondor, Creteil, France
9Hematology department, Hôpital Paul Brousse, Villejuif, France
10Service d'Hématologie Clinique, Centre Hospitalier Universitaire Brabois, Nancy, France
11Angers University Hospital, Angers, France
12French group of CML (Fi-LMC), Pessac, France
13Poitiers University Hospital, Poitiers, France
14Hematology Department, CHRU Lille, Lille, FRA
15Hematology Department, Centre Hospitalier de Versailles, LE CHESNAY CEDEX, France
16Laboratory of Hematology, University Hospital of Bordeaux, Hôpital Haut Lévêque, Pessac, France
17Centre Hospitalier Lyon Sud, Pierre Benite, FRA
18Cancer Center of Bordeaux, Institut Bergonié, INSERM U1218, University of Bordeaux, Bordeaux, France
1933 Hematology Departments, Centre Léon Bérard, Centre Hospitalier Lyon Sud, Pierre Bénite ; CRCL, Lyon, France
20INSERM U590, CRCL, Lyon, France

Hiroyuki Shimada, MD, PhD1*, Akihiro Watanabe, MD, PhD2*, Masaki Ito, MD, PhD3*, Chikako Tono, MD, PhD4*, Haruko Shima, MD, PhD1, Yuki Yuza, MD, PhD5*, Hideki Muramatsu, MD, PhD6, Masahiko Okada, MD, PhD7* and Akihiko Tanizawa, MD, PhD8*

1Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan
2Department of Pediatrics, Niigata Cancer Center Hospital, Niigata, Japan
3Department of Pediatrics, Fukushima Medical University School of Medicine, Fukushima, Japan
4Department of Pediatrics, Iwate Prefectural Chubu Hospital, Iwate, IWA, Japan
5Hematological Tumor Internal Medicine, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan
6Department of Pediatrics, Nagoya University Graduate School of Medicine, Aichi, Japan
7Misakae no Sono, Nagasaki, Japan
8Department of Pediatrics, Sugita Genpaku Memorial Obama Municipal Hospital, Fukui, Japan

Daniela Žácková, MD1*, Edgar Faber, MD, PhD2*, Lukáš Stejskal, MD3*, Michal Karas, MD, PhD4*, Petra Bělohlávková, MD, PhD5*, Hana Klamová, MD, PhD6*, Olga Černá, MD7*, Eduard Cmunt, MD, PhD8*, Petra Čičátková, MD1*, Lukáš Semerád, MD1*, Tomáš Horňák, MD1*, Anežka Kvetková, MD1*, Jiřina Procházková1*, Jitka Rychlíčková, PharmDr, PhD9*, Radka Štěpánová, MSc.9*, Adam Svobodník, PhD9*, Kateřina Machová Poláková, PhD6*, Ivana Ježíšková, PhD1*, Tomáš Jurček, PhD1*, Marek Borský, MSc.1*, Ondřej Wiewiorka, MSc.10*, Regina Demlová, MD, PhD9* and Jiří Mayer, Prof, MD1,11

1Department of Internal Medicine Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic
2Dpt. of Hemato-oncology, University Hospital Olomouc and Palacký University, Olomouc, Czech Republic
3Dpt. of Hemato-oncology, University Hospital Ostrava and Ostrava University, Ostrava, Czech Republic
4Dpt. of Hemato-oncology, University Hospital Plzeň and Charles University, Plzeň, Czech Republic
54th Department of Internal Medicine and Hematology, University Hospital Hradec Králové and Charles University, Hradec Králové, Czech Republic
6Institute of Hematology and Blood Transfusion, Prague, Czech Republic
7Dpt. of Internal Medicine Hematology, University Hospital Královské Vinohrady and Charles University, Prague, Czech Republic
81st Dpt. of Internal Medicine – Hematology, General University Hospital and Charles University, Prague, Czech Republic
9Department of Pharmacology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
10Dpt. of Biochemistry, University Hospital Brno, Brno, Czech Republic
11Central European Institute of Technology (CEITEC) Masaryk University, Brno, Czech Republic

John Brokars, MS1*, Arianna Kee, PharmD1*, Ali McBride1*, Sheila R. Reddy, PhD, MSc, RPh2*, Eunice Chang, PhD2*, Marian H. Tarbox, MPP2* and Thomas W. LeBlanc, MD, MA, MS3

1Bristol Myers Squibb, Princeton, NJ
2Partnership for Health Analytic Research, LLC, Beverly Hills, CA
3Duke University School of Medicine, Durham, NC

Susanne Isfort1,2,3*, Dominik Wolf, Univ. Prof., MD3,4,5,6*, Lino L. Teichmann5,6*, Martina Crysandt, MD1,2*, Andreas Burchert, MD7, Andreas Hochhaus, MD8, Susanne Saussele, MD 9, Alexander Kiani, MD10*, Joachim R. Göthert, MD11, Thomas Illmer, MD12*, Philippe Schafhausen, MD13*, Mareille Warnken-Uhlich14*, Uta Wolber14*, Denise Kohn15*, Kirsi Manz15*, Markus Pfirrmann, PhD15* and Tim H Brümmendorf, MD1,2

1Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Aachen, Germany
2Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, Aachen, Germany
3contributed equally, Aachen, Germany
4Department of Internal Medicine V (Hematology and Oncology), Innsbruck Medical University, Innsbruck, Austria
5Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Bonn, Germany
6Department of Medicine III, University Hospital Bonn, Germany, Bonn, Germany
7Department of Hematology, Oncology and Immunology, University Hospital Marburg, Marburg, Germany
8Department of Internal Medicine II, Jena University Hospital, Jena, Germany
9Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany
10Department of Medicine IV, Klinikum Bayreuth GmbH, Bayreuth, Germany
11Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
12Hematology-Oncology Practice, Dresden, Germany
13Department of Oncology, Hematology and BMT, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
14Clinical Study Core Unit Bonn, INstitute of Clinical Chemistry and Clinical Pharmacology, University Bonn, Bonn, Germany
15Institute for Medical Information Processing, Biometry and Epidemiology (IBE), Ludwig-Maximillians-University, München, Germany

Pavel Burda, PhD1,2*, Alzbeta Hlavackova, PhD1*, Vaclava Polivkova1*, Nikola Curik1,2*, Hana Klamová, MD, PhD1,3*, Jitka Koblihova1*, Jiri Suttnar, PhD1* and Katerina Machova1,2*

1Institute of Hematology and Blood Transfusion, Prague, Czech Republic
2Institute of Pathological Physiology, Charles University, First Faculty of Medicine, Prague, Czech Republic
3Institute of Clinical and Experimental Hematology of the First Faculty of Medicine, Charles University and Institute of Hematology and Blood Transfusion, Prague, Czech Republic

Fatima Khadadah, FRCPC1*, Anargyros Xenocostas, MD, FRCPC2, Lambert Busque, MD3, Kareem Jamani, MD4*, Sonia Cerquozzi, MD5, Philip Kuruvilla, MD6, Brian Leber, MD7, Rayan Kaedbey8, Sarit Assouline, MD, MSc9 and Dennis Dong Hwan Kim, MD, PhD10*

1Princess Margart Cancer Centre, University of Toronto, Toronto, ON, Canada
2Division of Hematology, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada
3Department of Hematology, Hôpital Maisonneuve-Rosemont, Montreal, QC, Canada
4Tom Baker Cancer Centre, Calgary, AB, Canada
5University of Calgary-Alberta Health Services, Rochester, AB, CAN
6The William Osler Health Ctr. Brampton Civic Hospital, Brampton, ON, CAN
7Division of Hematology, Juravinski Cancer Centre, Hamilton, ON, Canada
8McGill University, Montreal, Montreal, QC, CAN
9Segal Cancer Center, Jewish General Hospital, Montreal, QC, Canada
10Hans Messner Allogeneic Blood and Marrow Transplant Program, Department of Medical Oncology and Hematology, Princess Margaret Cancer Center, University Health Network, Toronto, ON, Canada

Praveen Sharma, MD, DNB, DM, SCYM (ASCP)1*, Man Updesh Singh Sachdeva, MD2*, Shano Naseem, MD3*, Sreejesh Sreedharanunni, MBBS, MD, DM3*, Reena Das, MD4, Pankaj Malhotra, MD5 and Neelam Varma, MD6

1Department of Hematology, Postgraduate Institute of Medical Education and Research, CHANDIGARH, India
2Department of Hematology, Postgraduate Institute of Medical Education and Research, Chandigarh, India, Chandigarh, India
3Department of Hematology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
4Department of Hematology, Postgraduate Institute of Medical Education & Research, Chandigarh, India
5Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India
6Department of Hematology, Postgraduate Institute of Medical Education and Research, Chandigarh, UT, India

Quinto J Gesiotto, MD1, Akriti G Jain, MD2, Somedeb Ball, MD2, Lisa Nodzon, PhD, ARNP, AOCNP3*, Amanda Rodriguez, PA3*, Rami S. Komrokji, MD3, David A. Sallman, MD2, Eric Padron, MD3, Andrew T. Kuykendall, MD2, Onyee Chan, MD2, Jeffrey E. Lancet, MD2, Javier Pinilla Ibarz, MD, PhD2 and Kendra Sweet, MD2

1Department of Medicine, University of South Florida, Tampa, FL
2Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
3Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL

Amer M. Zeidan, MD1,2, Kevin Roopcharan3*, Jerry P. Radich, MD4,5, Jan Bewersdorf, MD6*, Vijaya R. Bhatt, MD7, Elad Sharon, MD, MPH8*, Richard F. Little, MD, MPH9,10, Steven D. Gore, MD6,10,11, Anne Caldwell12*, Selina M. Luger, MD, FRCPC13 and Mark R. Litzow, MD14

1Department of Internal Medicine, Section of Hematology, Yale University School of Medicine, East Haven, CT
2Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University School of Medicine, New Haven, CT
3Dana-Farber Cancer Institute, Boston
4Department of Medicine, University of Washington, Seattle, WA
5Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
6Department of Internal Medicine, Section of Hematology, Yale University School of Medicine, New Haven, CT
7University of Nebraska Medical Center, Omaha, NE
8Division of Cancer Treatment and Diagnosis, National Cancer Institute, Cancer Therapy Evaluation Program, Bethesda, MD
9National Cancer Institute, Washington, DC
10Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD
11Yale Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, CT
12Yale cancer center, Yale University, new haven, CT
13Cellular Therapy and Transplantation, Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA
14Division of Hematology, Mayo Clinic, Rochester, MN

Michele Muir, PharmD1*, Jasmine Johnson, BS2*, Sitong Shu, BS2*, Hui-Han Chen, MHS, BS3*, Sachiko Ozawa, PhD, MHS4* and Benyam Muluneh, PharmD5

1Divison of Pharmacotherapy and Experimental Therapeutics, University of North Carolina at Chapel Hill Eshelman School of Pharmacy, Carrboro, NC
2University of North Carolina at Chapel Hill Eshelman School of Pharmacy, Chapel Hill, NC
3Division of Pharmaceutical Outcomes and Policy, University of North Carolina at Chapel Hill Eshelman School of Pharmacy, Chapel Hill, NC
4Division of Practice Advancement and Clinical Education, University of North Carolina at Chapel Hill Eshelman School of Pharmacy, Chapel Hill, NC
5Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina at Chapel Hill Eshelman School of Pharmacy, Chapel Hill, NC

Dan Yu1*, Zhuangzhi Yang2*, Hui Cheng1*, Rui Jiang3*, Jingming Guo4*, Chucheng Wan5*, Jun Qin6*, Youshan Zhang7*, Guolin Yuan8*, Daozi Jiang9*, Chun Zhang10*, Fang Liu10*, Min Zhang10*, Shiming Chen11*, Caixia Liang7*, Jing Zou10*, Zhiwei Wu3*, Xiuping Zou2*, Danlei Han4*, Xu Chen5*, Li Wang6*, Tingting Lv8*, Xiaolong Tian8*, Yanping Xie3*, Hongyu An11*, Li Yan9*, Yicheng Zhang12 and Weiming Li10*

1Wuhan No.1 Hospital, Wuhan, China
2Suizhou Central Hospital corresponding, Suizhou, China
3Jingmen No.1 people's hospital, Jingmen, China
4Yichang Central People's hospital, Yichang, China
5Shiyan Taihe hospital, Shiyan, China
6Shiyan people's hospital, Shiyan, China
7Jingzhou No.1 People's hospital, Jingzhou, China
8Department of Hematology, Xiangyang Central Hospital,Affiliated Hospital of Hubei, Xiangyang, China
9Department of Hematology, Wuhan University Renmin Hospital, Wuhan University, Wuhan, China
10Union Hospital,Tongji Medical College,Huazhong University of Science and Technology, Wuhan, China
11Huangshi central hospital, Huangshi, China
12Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan, China

Jie Jin, MD, PhD1,2, Li Meng3*, Wenjuan Yu, MD, PhD1*, Peng Liu, MD4,5, Xin Du6*, Jin Lou, master7* and Weiguang Wang4*

1Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
2The First Affiliated Hospital, Zhejiang University of Medicine, Hangzhou, China
3Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
4Department of Hematology, Zhongshan Hospital Fudan University, Shanghai, China
5Department of Hematology, Zhongshan Hospital, Fudan University, Shanghai, China
6Division of Hematology, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, China
7Department of Hematology, Shenzhen Second People’s Hospital, The Institute of Hematology in Shenzhen, The First Affiliated Hospital of Shenzhen University, Shenzhen Bone Marrow Transplantation Public Service Platform, Shenzhen 518035, China, Shenzhen, China

Roberto Latagliata1*, Isabella Capodanno, MD2*, Maria Cristina Miggiano, MD3*, Cristina Bucelli, MD4*, Francesco Cavazzini, MD5*, Sabrina Leonetti Crescenzi, MD6*, Sabina Russo, MD7*, Gioia Colafigli, MD8*, Mario Annunziata, MD9*, Federica Sora, MD10*, Massimiliano Bonifacio, MD11*, Luigiana Luciano, MD12, Giovanni Caocci, MD13, Giuseppina Loglisci, MD14*, Chiara Elena, MD15*, Rikard Mullai, MD16*, Imma Attolico, MD17*, Gianni Binotto, MD18*, Elena Crisà, MD19*, Alessandra Iurlo, MD, PhD4*, Paolo Sportoletti, MD20*, Ambra Di Veroli, MD1*, Anna Rita Scortechini, MD21*, Annapaola Leporace, MD22*, Alessandro Maggi, MD23*, Monica Crugnola, MD24*, Fabio Stagno, MD, PhD25, Rosaria Sancetta, MD26*, Pamela Murgano, MD27*, Davide Rapezzi, MD28*, Debora Luzi29*, Monica Bocchia30*, Carmen Fava, M.D.31, Alessandra Malato, MD, PhD32*, Jolanda Donatella Vincelli33*, Elisabetta Abruzzese, MD34, Giuseppe Nicola Saglio, MD, PhD35, Giorgina Specchia, MD36, Massimo Breccia, MD37* and Mario Tiribelli, MD38*

1Hematology, Belcolle Hospital, Viterbo, Italy
2Hematology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, Italy
3Hematology Department, San Bortolo Hospital, Azienda ULSS8 "Berica" di Vicenza, Vicenza, Italy
4Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
5Division of Hematology, Department of Medical Sciences, University of Ferrara, Azienda Ospedaliera-Universitaria, Arcispedale S. Anna, Ferrara, Italy
6Hematology Unit, San Giovanni Hospital, Rome, Italy
7Division of Hematology, Policlinico “G. Martino”, University of Messina, Messina, Italy
8Department of Traslational and Precision Medicine - Hematology, University Sapienza, Rome, Italy
9Hematology Unit, Azienda Ospedaliera Cardarelli, Naples, Italy
10Hematology Unit, Fondazione Policlinico Universitario Gemelli IRCCS, Rome, Italy
11Department of Medicine, Section of Hematology, University of Verona, Verona, Italy
12Hematology Unit, Federico II University of Naples, Napoli, Italy
13Hematology Unit, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, ITA
14Hematology Unit, Vito Fazzi Hospital, Lecce, Italy
15Department of Hematology Oncology, Foundation IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy
16Hematology, University of Udine, Udine, Italy
17Hematology and Stem Cell Transplantation Unit, AOUC Policlinico, Bari, Italy
18Department of Medicine, Hematology and Clinical Immunology, Padua School of Medicine, Padua, Italy
19Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale Amedeo Avogadro, AOU Maggiore della Carità, Novara, Italy
20Institute of Hematology and Center of Hemato-Oncology Research (CREO), University of Perugia, Perugia, Italy
21Division of Hematology, Department of Molecular and Clinical Sciences, Polytechnic University of Marche, Ancona, Italy
22Hematology Unit, Azienda Ospedaliero Universitaria Sant' Andrea, Rome, Italy
23Division of Hematology, Hospital "S.G. Moscati", Taranto, Italy
24Hematology and BMT Center, Department of Medicine and Surgery, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
25Chair and Hematology Section, Ferrarotto Hospital, Catania, Italy
26Hematology Unit, Ospedale dell'Angelo, Venizia-Mestre, Italy
27Division of Hematology, S. Elia Hospital, Caltanissetta, Italy
28S.C. Ematologia, ASO S. Croce e Carle, Cuneo, Italy
29Hematology, Azienda Ospedaliera - S. Maria Terni, Terni, ITA
30Hematology, Hematology Unit, University of Siena, Azienda Ospedaliero Universitaria Senese, Siena, Italy
31Hematology Division, Ospedale Mauriziano, University of Turin, Torino, Italy
32Department of Hematology, Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy
33Hematology Unit, Grande Ospedale Metropolitano "Bianchi-Melacrino-Morelli", Reggio Calabria, Italy, REGGIO CALABRIA, Italy
34Hematology, S. Eugenio Hospital, Tor Vergata University, Rome, Italy
35Divisione Universitaria di Ematologia e Terapie Cellulari, A.O. Ordine Mauriziano, Turin, Italy
36Hematology Section, Department of Emergency and Transplantation - GIMEMA WP CML, University of Bari Aldo Moro, Bari, Italy
37Department of Translational and Precision Medicine, University "Sapienza", Roma, Italy
38Division of Hematology and BMT, Department of Medical Area, University of Udine, Udine, Italy

*signifies non-member of ASH